Lucas Kuhne

Koeln, NW, Germany

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 22 publications

Revisiting clinical response and refractoriness in immune thrombotic thrombocytopenic purpura.

Revisiting clinical response and refractoriness in immune thrombotic thrombocytopenic purpura.

Journal: Blood

Published: October 14, 2025

Revisiting Clinical Response and Refractoriness in Immune Thrombotic Thrombocytopenic Purpura.

Revisiting Clinical Response and Refractoriness in Immune Thrombotic Thrombocytopenic Purpura.

Journal: Blood

Published: October 14, 2025

Characteristics and Management of Patients With Immune Thrombotic Thrombocytopenic Purpura Admitted to the Intensive Care Unit: A Multicenter Retrospective Analysis.

Characteristics and Management of Patients With Immune Thrombotic Thrombocytopenic Purpura Admitted to the Intensive Care Unit: A Multicenter Retrospective Analysis.

Journal: American journal of hematology

Published: August 07, 2025

100 years thrombotic thrombocytopenic purpura (TTP) - lessons learned?

100 years thrombotic thrombocytopenic purpura (TTP) - lessons learned?

Journal: Deutsche medizinische Wochenschrift (1946)

Published: November 06, 2024

Caplacizumab use in immune-mediated thrombotic thrombocytopenic purpura: an international multicentre retrospective Cohort study (The Capla 1000+ project).

Caplacizumab use in immune-mediated thrombotic thrombocytopenic purpura: an international multicentre retrospective Cohort study (The Capla 1000+ project).

Journal: EClinicalMedicine

Published: October 21, 2024

Erratum to "Features of Postpartum Hemorrhage-Associated Thrombotic Microangiopathy and Role of Short-Term Complement Inhibition" [Kidney International Reports Volume 9, Issue 4, April 2024, Pages 919-928].

Erratum to "Features of Postpartum Hemorrhage-Associated Thrombotic Microangiopathy and Role of Short-Term Complement Inhibition" [Kidney International Reports Volume 9, Issue 4, April 2024, Pages 919-928].

Journal: Kidney international reports

Published: October 21, 2024

Challenges and Considerations in Managing Thrombotic Microangiopathy and Disseminated Intravascular Coagulation in Postpartum Hemorrhage.

Challenges and Considerations in Managing Thrombotic Microangiopathy and Disseminated Intravascular Coagulation in Postpartum Hemorrhage.

Journal: Kidney international reports

Published: May 18, 2024

Clinical efficacy and safety of switching from eculizumab to ravulizumab in adult patients with aHUS- real-world data.

Clinical efficacy and safety of switching from eculizumab to ravulizumab in adult patients with aHUS- real-world data.

Journal: BMC nephrology

Published: January 13, 2024

Management of immune thrombotic thrombocytopenic purpura without therapeutic plasma exchange.

Management of immune thrombotic thrombocytopenic purpura without therapeutic plasma exchange.

Journal: Blood

Published: December 27, 2023

Features of Postpartum Hemorrhage-Associated Thrombotic Microangiopathy and Role of Short-Term Complement Inhibition.

Features of Postpartum Hemorrhage-Associated Thrombotic Microangiopathy and Role of Short-Term Complement Inhibition.

Journal: Kidney international reports

Published: October 01, 2023

Repetitive administration of rituximab can achieve and maintain clinical remission in patients with MCD or FSGS.

Repetitive administration of rituximab can achieve and maintain clinical remission in patients with MCD or FSGS.

Journal: Scientific reports

Published: October 15, 2022

Impact of first-line use of caplacizumab on treatment outcomes in immune thrombotic thrombocytopenic purpura.

Impact of first-line use of caplacizumab on treatment outcomes in immune thrombotic thrombocytopenic purpura.

Journal: Journal of thrombosis and haemostasis : JTH

Published: July 01, 2022

Showing 1-12 of 22

Last Updated: 09/26/2026